Ensayos clínicos Mayo Clinic en Rochester, Minnesota, Mayo Clinic en Jacksonville (Florida), y Mayo Clinic en Phoenix y Scottsdale (Arizona), se encuentran entre los mejores hospitales de oncología según la clasificación de U.S. News & World Report. Mayo Clinic en Rochester, Minnesota, ocupa el primer puesto entre los mejores hospitales especializados en trastornos digestivos, según la clasificación de U.S. News & World Report. Mayo Clinic de Phoenix y Scottsdale, Arizona, y Mayo Clinic de Jacksonville, Florida, se encuentran entre los mejores hospitales para trastornos digestivos, según la clasificación de U.S. News & World Report. De acuerdo con la selección de los “Mejores Hospitales Pediátricos” de U.S. News & World Report 2023-2024, el Centro Pediátrico de Mayo Clinic en Rochester está clasificado como el hospital n.º 1 en Minnesota y en la región de los cinco estados de Iowa, Dakota del Norte, Dakota del Sur y Wisconsin. A continuación, se enumeran los ensayos clínicos actuales.5 estudios en Cirugía de colon y recto (solo estudios abiertos). Filtra esta lista de estudios por sede, estatus, etc. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery Rochester, Minn., Scottsdale/Phoenix, Ariz. The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs 5-fluorouracil/capecitabine and radiation therapy) prior to surgery. Although radiation therapy to the pelvis has been a standard and important part of treatment for rectal cancer and has been shown to decrease the risk of the cancer coming back in the same area in the pelvis, some patients experience undesirable side effects from the radiation and there have been important advances in chemotherapy, surgery, and radiation which may be of benefit. The purpose of this study is to compare the effects, both good and bad, of the standard treatment of chemotherapy and radiation to chemotherapy using a combination regimen known as FOLFOX, (the drugs 5-fluorouracil (5-FU), oxaliplatin and leucovorin) and selective use of the standard treatment, depending on response to the FOLFOX. The drugs in the FOLFOX regimen are all FDA (Food and Drug Administration) approved and have been used routinely to treat patients with advanced colorectal cancer. A Safety to Evaluate the Safety and Effectiveness of Pressurized Intraperitoneal Aerosolized Chemotherapy in Ovarian, Uterine, Colorectal, and Gastric Cancer Patients Jacksonville, Fla. The purpose of this study is to evaluate the safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in 2 groups of patients with peritoneal carcinomatosis (PC), either due to primary ovarian, uterine, or gastric carcinoma (Arm 1) or to primary colorectal carcinoma (Arm 2), based on treatment-related adverse events reported by National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects Rochester, Minn. The primary purpose of this study is to characterize the microbes that are causal of colorectal cancer and those that are merely conditions of the tumor. This will be accomplished by comparing the microbiomes before and after resection. A Study to Analyze AVB-114 to Treat Complex Crohn’s Perianal Fistulas in Subjects with Quiescent Rectal Disease Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine whether AVB-114 compared to standard of care treatment is effective in inducing remission of the treated complex perianal fistula in subjects with Crohn’s Disease. It also aims to assess clinical and radiologic components of fistula remission, safety of treatment, disease activity, patient Quality of Life, and patient care journey, between AVB-114 and standard of care treatment. A Study to Examine Financial Distress in Patients Undergoing Treatment of Locally-advanced Rectal Cancer Scottsdale/Phoenix, Ariz. The purpose of this study is to examine the needs and gap in our understanding of financial burden experienced by rectal cancer patients from a patient perspective to help provide patient centered care and improve psychosocial outcomes of this group. Solicite una consulta Ubicaciones, viajes y alojamientoInvestigación March 19, 2022 Comparte en: FacebookTwitter Cirugía de colon y rectoPágina inicialdel departamentoSeccionesSolicitar una consultaDescripción generalPruebas y procedimientosTrastornos que se tratanMédicosConocimientos y categoríasUbicaciones, viajes y alojamientoEnsayos clínicosInvestigaciónCostos y seguro médicoNoticias de Mayo ClinicRemisiones Investigación: todo es por los pacientes Mostrar la transcripción Para video Investigación: todo es por los pacientes [MUSIC PLAYING] Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to put it in its own spotlight. SeccionesSolicitar una consultaDescripción generalPruebas y procedimientosTrastornos que se tratanMédicosConocimientos y categoríasUbicaciones, viajes y alojamientoEnsayos clínicosInvestigaciónCostos y seguro médicoNoticias de Mayo ClinicRemisiones ORG-20310670 Centros y departamentos médicos Cirugía de colon y recto